301093SZSE
🚨 Material Event

Announcement of Resolutions from the 17th Meeting of the 6th Board of Directors

✨ AI Summary

The 17th meeting of the 6th Board of Directors of Jiangsu Hualan Pharmaceutical New Materials Co., Ltd. was held on May 29, 2026. The board unanimously approved an investment proposal by its wholly-owned subsidiary, Hainan Lingqing Intelligent Pharmaceutical Technology Co., Ltd., in Wuxi Natural Constant Technology Co., Ltd. This investment aims to enhance the company's strategic positioning in the AI pharmaceutical sector and strengthen its core competitiveness.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

I. Meeting Information

The notice for the 17th meeting of the 6th Board of Directors of Jiangsu Hualan Pharmaceutical New Materials Co., Ltd. (hereinafter referred to as "the Company") was sent to all directors via email and phone on May 19, 2026. The meeting was held on May 29, 2026, in the company meeting room, combining in-person and remote attendance. The meeting was convened and presided over by Mr. Hua Yimin, the chairman of the company. There were 9 directors eligible to attend, and all 9 directors were present. Mr. Xiao Feng, Ms. Cui Ke, Ms. Yao Mingfang, Mr. Shan Tichao, Mr. Chen Gang, Mr. Liu Li, and Mr. Hou Xuchao attended the meeting via remote voting, and senior management of the company were present. The convening, holding, and voting of this meeting complied with the provisions of the Company Law and other relevant laws, regulations, normative documents, and the Ar

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.